Second Line Capital »

Viking Therapeutics shares owned by Second Line Capital

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Second Line Capital from 13F filings

Historical chart of Second Line Capital investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Second Line Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Second Line Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4M 38k 63.31
2024-06-30 $1.5M 28k 53.01

More positions owned by Second Line Capital

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Etf Ser Solutions Aptus Drawdown (ADME)
Etf Ser Solutions Aptus Enhanced (JUCY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Large Cap (DUBS)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
Apple (AAPL)

View all positions for Second Line Capital

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
Jane Street

View all funds holding Viking Therapeutics